Luye Pharma terminated the agreements in...

2015/06/02
A leading innovative pharmaceutical company with strong R&D capability and global vision in China market—Luye Pharma Group Ltd. (the “Company”, together with its subsidiaries, “Luye”, stock code: 2186.HK), announced that the Company served notices terminating the Agreements in relation to the Co...

Sort
Name
About Us Marketed Products R&D Media Center Investor relations Join us Contact Us